Stock listing
NYSE:CRL Charles River Laboratories International, Inc. Stock
Home listing (NYSE) of Charles River Laboratories International, Inc.
Follow Charles River Laboratories International, Inc. into a list and get an email when it puts out news.
Share price · NYSE:CRL
$344.87 USD +29.42 (+9.3%)
Close on Oct 21, 2026
- Day range
- $313.83 – $348.95 USDOct 21, 2026
- Volume
- 2.74M sharesOct 21, 2026
- Market cap
- $16.61B USDAt the close on Oct 21, 2026 · price × 48.17M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:CRL · Home | $344.87 USD | +29.42 (+9.3%) | 2,744,894 | $313.83 | $348.95 | $313.83 | $315.45 | Close on Oct 21, 2026 |
| Frankfurt:RV6 | €280.20 EUR | +13.70 (+5.1%) | 32 | €280.20 | €280.20 | €280.20 | €266.50 | Close on Oct 21, 2026 |
| Munich:RV6 | €280.30 EUR | +11.65 (+4.3%) | — | €280.30 | €280.30 | €280.30 | €268.65 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · NYSE:CRL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $344.87 | +29.42 | +9.3% | $313.83 | $348.95 | $313.83 | 2,744,894 | |
| $315.45 | +15.43 | +5.1% | $308.84 | $317.56 | $304.00 | 1,272,223 | |
| $300.02 | -0.13 | 0.0% | $303.33 | $305.77 | $297.56 | 489,433 | |
| $300.15 | -6.09 | -2.0% | $306.09 | $308.46 | $296.35 | 674,573 | |
| $306.24 | +4.24 | +1.4% | $301.81 | $309.48 | $295.51 | 919,489 | |
| $302.00 | +2.98 | +1.0% | $297.53 | $310.53 | $296.00 | 941,300 | |
| $299.02 | -2.84 | -0.9% | $301.00 | $302.77 | $295.15 | 753,141 | |
| $301.86 | +0.07 | 0.0% | $301.80 | $303.10 | $299.27 | 543,800 | |
| $301.79 | +3.79 | +1.3% | $294.60 | $305.21 | $294.60 | 679,800 | |
| $298.00 | -2.30 | -0.8% | $297.01 | $298.27 | $288.43 | 1,176,900 | |
| $300.30 | -4.66 | -1.5% | $303.38 | $305.18 | $294.28 | 1,242,200 | |
| $304.96 | -5.81 | -1.9% | $319.80 | $333.30 | $300.01 | 1,923,100 | |
| $310.77 | +20.58 | +7.1% | $292.05 | $312.26 | $292.02 | 1,305,600 | |
| $290.19 | +3.36 | +1.2% | $287.91 | $290.61 | $285.75 | 443,500 | |
| $286.83 | -8.18 | -2.8% | $291.86 | $297.00 | $284.61 | 823,000 | |
| $295.01 | -0.95 | -0.3% | $296.97 | $298.98 | $293.46 | 794,100 | |
| $295.96 | +1.37 | +0.5% | $294.71 | $298.20 | $289.38 | 661,450 | |
| $294.59 | +1.75 | +0.6% | $289.13 | $296.88 | $289.13 | 901,741 | |
| $292.84 | -1.60 | -0.5% | $293.19 | $295.23 | $287.23 | 838,300 | |
| $294.44 | +17.11 | +6.2% | $277.00 | $298.40 | $276.95 | 1,590,800 | |
| $277.33 | -7.78 | -2.7% | $283.85 | $291.09 | $276.64 | 1,594,200 | |
| $285.11 | +6.10 | +2.2% | $280.19 | $290.11 | $277.41 | 1,137,111 | |
| $279.01 | +0.95 | +0.3% | $279.37 | $281.63 | $275.88 | 952,932 | |
| $278.06 | -3.61 | -1.3% | $281.26 | $283.00 | $276.00 | 1,481,200 | |
| $281.67 | +8.26 | +3.0% | $280.11 | $285.58 | $274.40 | 809,800 | |
| $273.41 | +0.53 | +0.2% | $272.78 | $282.91 | $270.88 | 1,014,800 | |
| $272.88 | -0.23 | -0.1% | $272.27 | $276.09 | $269.93 | 983,700 | |
| $273.11 | -5.15 | -1.9% | $278.27 | $279.64 | $267.27 | 1,385,100 | |
| $278.26 | +5.26 | +1.9% | $276.01 | $280.40 | $275.63 | 767,600 | |
| $273.00 | -5.35 | -1.9% | $275.38 | $275.88 | $272.06 | 764,700 | |
| $278.35 | -2.41 | -0.9% | $278.54 | $280.75 | $275.00 | 789,200 | |
| $280.76 | -7.74 | -2.7% | $285.60 | $285.94 | $280.16 | 729,100 | |
| $288.50 | -4.85 | -1.7% | $288.29 | $291.69 | $285.34 | 738,900 | |
| $293.35 | +1.59 | +0.5% | $294.21 | $295.77 | $285.56 | 646,300 | |
| $291.76 | +9.42 | +3.3% | $285.49 | $292.55 | $282.56 | 606,500 | |
| $282.34 | -5.90 | -2.0% | $289.26 | $290.53 | $280.91 | 705,700 | |
| $288.24 | -3.26 | -1.1% | $285.91 | $291.41 | $284.34 | 1,086,200 | |
| $291.50 | -4.91 | -1.7% | $291.66 | $294.89 | $289.60 | 659,800 | |
| $296.41 | +1.31 | +0.4% | $297.01 | $303.31 | $295.93 | 901,300 | |
| $295.10 | -2.54 | -0.9% | $293.17 | $299.53 | $290.01 | 1,231,100 | |
| $297.64 | -0.94 | -0.3% | $299.93 | $300.59 | $295.36 | 883,481 | |
| $298.58 | +3.39 | +1.1% | $297.63 | $299.02 | $290.73 | 786,066 | |
| $295.19 | +3.74 | +1.3% | $291.78 | $298.18 | $289.07 | 887,500 | |
| $291.45 | +1.45 | +0.5% | $285.72 | $299.32 | $281.73 | 1,059,300 | |
| $290.00 | +10.81 | +3.9% | $284.22 | $294.56 | $280.68 | 987,400 | |
| $279.19 | -7.45 | -2.6% | $286.40 | $289.60 | $279.06 | 703,700 | |
| $286.64 | +6.59 | +2.4% | $279.48 | $288.88 | $279.03 | 856,800 | |
| $280.05 | -1.22 | -0.4% | $280.06 | $283.20 | $276.66 | 750,400 | |
| $281.27 | -3.10 | -1.1% | $286.30 | $287.79 | $278.84 | 1,054,900 | |
| $284.37 | +2.37 | +0.8% | $282.92 | $288.02 | $280.00 | 1,166,400 | |
| $282.00 | +5.00 | +1.8% | $274.86 | $282.39 | $271.84 | 1,180,200 | |
| $277.00 | +9.51 | +3.6% | $265.65 | $277.07 | $265.49 | 1,025,300 | |
| $267.49 | +1.98 | +0.7% | $261.53 | $267.59 | $260.82 | 612,500 | |
| $265.51 | +4.79 | +1.8% | $264.89 | $268.00 | $255.79 | 1,307,400 | |
| $260.72 | +26.60 | +11.4% | $267.99 | $267.99 | $252.07 | 1,782,400 | |
| $234.12 | +3.25 | +1.4% | $234.33 | $237.24 | $228.52 | 1,146,546 | |
| $230.87 | -1.64 | -0.7% | $233.29 | $235.70 | $228.01 | 608,144 | |
| $232.51 | -2.11 | -0.9% | $235.71 | $237.06 | $230.06 | 509,200 | |
| $234.62 | -0.18 | -0.1% | $234.55 | $235.50 | $227.38 | 937,700 | |
| $234.80 | -5.63 | -2.3% | $240.64 | $242.40 | $234.18 | 1,054,500 | |
| $240.43 | +16.13 | +7.2% | $232.30 | $242.73 | $231.50 | 1,257,900 | |
| $224.30 | -2.28 | -1.0% | $225.86 | $227.49 | $222.68 | 720,300 | |
| $226.58 | -2.71 | -1.2% | $230.23 | $231.98 | $225.03 | 476,100 | |
| $229.29 | +10.59 | +4.8% | $234.07 | $238.85 | $224.28 | 1,075,100 | |
| $218.70 | -0.70 | -0.3% | $218.19 | $221.83 | $216.99 | 570,800 | |
| $219.40 | -0.30 | -0.1% | $215.57 | $223.62 | $213.40 | 925,000 |
- Ticker
- NYSE:CRL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
Latest earnings call · Aug 5, 2026
Charles River Laboratories International (NYSE:CRL) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 24, 2026
Investor Day (September 2026)
Investor day · 123 slides
Calls
Upcoming
Charles River Laboratories International (NYSE:CRL) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 9:00 AM ET
Register
Replays
Charles River Laboratories International (NYSE:CRL) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 9:00 AM ET
Watch TranscriptCharles River Laboratories International (NYSE:CRL) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:30 AM ET
Watch TranscriptCharles River Laboratories International (NYSE:CRL) Q4 2025 Earnings Call
Wed, Feb 18, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
Oct 13, 2026
Closed $299.02 (-0.9%) on Oct 13, 2026
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
Oct 9, 2026
Closed $301.79 (+1.3%) on Oct 9, 2026
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
Oct 6, 2026
Closed $304.96 (-1.9%) on Oct 6, 2026
Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day
Sep 24, 2026
Closed $294.44 (+6.2%) on Sep 24, 2026
Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines
Sep 17, 2026
Closed $281.67 (+3.0%) on Sep 17, 2026
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences
Sep 11, 2026
Closed $278.26 (+1.9%) on Sep 11, 2026
Charles River Modernizes Endosafe(R) Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
Sep 9, 2026
Closed $278.35 (-0.9%) on Sep 9, 2026
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
Sep 8, 2026
Closed $280.76 (-2.7%) on Sep 8, 2026
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
Aug 20, 2026
Closed $291.45 (+0.5%) on Aug 20, 2026
Charles River Laboratories Announces Second-Quarter 2026 Results
Aug 5, 2026
Closed $260.72 (+11.4%) on Aug 5, 2026
Decks
Investor Day (September 2026)
Investor day · 123 slides · Sep 24, 2026
Q2 2026 Earnings Presentation
Earnings · 26 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 25 slides · May 7, 2026
Q4 2025 Earnings Presentation
Earnings · 53 slides · Feb 18, 2026
Charles River Laboratories International, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 39 in the last 12 months · 64 in all · newest Oct 13, 2026 · oldest 2025
- Calls
- 25 calls with a replay · 25 with a transcript · latest Aug 5, 2026
- Decks
- 43 decks · latest Sep 24, 2026
Where Charles River Laboratories International, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:CRL · Home listing · This page | NYSE | United States | USD |
| gettex:RV6 | gettex | Germany | EUR |
| LS Exchange:939391 | LS Exchange | Germany | EUR |
| Lang & Schwarz:939391 | Lang & Schwarz | Germany | EUR |
| BMV:CRL | BMV | Mexico | MXN |
| Stuttgart:RV6 | Stuttgart | Germany | EUR |
| Frankfurt:RV6 | Frankfurt | Germany | EUR |
| Tradegate:RV6 | Tradegate | Germany | EUR |
| BIVA:CRL | BIVA | Mexico | MXN |
| BOATS:CRL | BOATS | United States | USD |
| LSE:0ADA | LSE | United Kingdom | USD |
| BX Swiss:RV6 | BX Swiss | Switzerland | CHF |
| Dusseldorf:RV6 | Dusseldorf | Germany | EUR |
| Hamburg:RV6 | Hamburg | Germany | EUR |
| Munich:RV6 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Charles River Laboratories International, Inc.